Padkao Tadsawiya, Intakhiao Suwipa, Prakobkaew Nattaphol, Buddhisa Surachat, Teethaisong Yothin, Boonla Orachorn, Prasertsri Piyapong
Faculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Int J Mol Sci. 2025 Sep 4;26(17):8623. doi: 10.3390/ijms26178623.
Long COVID is characterized by persistent symptoms associated with chronic inflammation and oxidative stress. While high-intensity interval training (HIIT) and supplementation with antioxidants such as have demonstrated individual therapeutic benefits, their combined effects remain unclear. This study aimed primarily to evaluate the effects of an 8-week HIIT program on markers of inflammation, oxidative stress, and exercise-related symptoms in individuals with long COVID, and secondarily to explore whether supplementation provided additional benefits. A total of 104 participants (aged 18-59 years) were randomized into three groups-control (placebo), HIIT (cycling for 28 min/day, 3 days/week), and combined (HIIT + , 1000 mg/day)-for 8 weeks. The biomarkers assessed included interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), protein carbonyls, and superoxide dismutase (SOD) activity. Following the intervention, significant reductions in IFN-γ, TNF-α, MDA, protein carbonyls, and rating of perceived exertion were observed in both the HIIT and combined groups ( < 0.05), with no significant differences between the two. SOD activity significantly increased in all groups, including the control group ( < 0.05), with no between-group differences. An 8-week HIIT program appears to be effective in reducing inflammation, oxidative stress, and dyspnea in individuals with long COVID. supplementation did not provide any additional statistically significant benefit but was safe and well tolerated.
长新冠的特征是与慢性炎症和氧化应激相关的持续症状。虽然高强度间歇训练(HIIT)和补充抗氧化剂等已显示出个体治疗益处,但其联合效果仍不明确。本研究主要旨在评估为期8周的HIIT计划对长新冠患者炎症、氧化应激和运动相关症状标志物的影响,其次是探讨补充剂是否能带来额外益处。总共104名参与者(年龄在18 - 59岁之间)被随机分为三组——对照组(安慰剂)、HIIT组(每天骑行28分钟,每周3天)和联合组(HIIT + ,每天1000毫克),为期8周。评估的生物标志物包括干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)、丙二醛(MDA)、蛋白质羰基和超氧化物歧化酶(SOD)活性。干预后,HIIT组和联合组的IFN-γ、TNF-α、MDA、蛋白质羰基以及主观用力程度评分均显著降低(P < 0.05),两组之间无显著差异。所有组,包括对照组,SOD活性均显著增加(P < 0.05),组间无差异。为期8周的HIIT计划似乎能有效减轻长新冠患者的炎症、氧化应激和呼吸困难。补充剂未提供任何额外的统计学显著益处,但安全且耐受性良好。